Full Text:

 

영남의대학술지 Vol.24_No.2 Suppl. P.S652-657, Dec. 2007

Case Report

자궁경부에 발생한 투명세포암 1 예

A Case of Clear Cell Adenocarcinoma of the Uterine Cervix

박성철, 박윤기, 이두진, 이승호
영남대학교 의과대학 산부인과학교실
책임저자:이승호, 대구광역시 남구 대명5동 317-1, 영남대학교 의과대학 산부인과학교실
Tel: (053) 620-3431, Fax: (053) 654-0676
E-mail: shlee@med.yu.ac.kr

December 30, 2007

Abstract

Clear cell adenocarcinoma of cervix is a very rare malignancy of the uterine cervix. The etiology and pathogenesis are unclear. Clear cell adenocarcinomas have been reported most commonly in women with a history of in utero exposure to diethylstilbesterol (DES), these tumors also can develope in the absence of exposure to DES. These tumors account for 4% to 9% of adenocarcinomas of the cervix.
We report a case of clear cell adenocarcinoma in the uterine cervix of 40 years-old women who was not related to DES with a brief review of literature.

Key Words: Clear cell adenocarcinoma, Cervical cancer, DES

References

1. Silverberg SG, De Giorgi LS. Clear cell carcinoma of endometrium; clinical, pathologic, and ultrastructual findings. Cancer 1973 May; 31(5):1127-40.

2. 김철중, 박창수, 이정원, 이수호, 이선주, 김병기 등. 성경험이 없는 22세 여성 자궁경부에서 발생한 투명세포암 1예. 대한산부회지 2004;47(7): 1409-14.

3. 나수미, 오성환, 김흥곤, 문형배. Diethylstilbesterol과 관련이 없는 자궁경부 투명세포암 1예. 대한산부회지 2007;50(3):539-44.

4. Meyer R. Uber Adenom- and Karzinombildung and der Ampulle des Gartnerschen Ganges. Virchows Arch. F. Path. Anat 1903;174:270-94.

5. Saigo PE, Cain JM, Kim WS, Gaynor JJ, Johnson K, Lewis JL. Prognostic factors in adenocarcinoma of the uterine cervix. Cancer 1986 Apr;57(8):1584-93.

6. 이혜경, 차동수, 김대현, 최성덕, 이영진, 김영민. 자궁경부 투명세포암 1예. 대한산부회지 1987; 60:689-93.

7. Scully RE, Barlow JF. Mesonephroma ovarii. Am J Cancer 1939;35:1-21.

8. Reich O, Tamussino K, Lahousen M, Pickel H, Hass J, Winter R. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB - IIB disease in women not exposed in utero to diethylstilbes- terol. Gynecol Oncol 2000 May;76(3):331-5.

9. Frosberg JG, Kalland T. Embryology of the genital tract in human and rodents; developmental effect of DES in pregnancy. New York: Thiema-Stratton;1981;1-15.

10. Herbst AL, Robboy SJ, Scully RE, Poskanzer DC. Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Gynecol 1974 Jul;119(5):713-24.

11. Waggoner SE, Baunoch DA, Anderson SA, Leigh F, Zagaja VG. Bcl-2 protein expression associated with resistance to apoptosis in clear cell adenocarcinoma of the vagina and cervix expressing wild-type P53. Ann Surg Oncol 1998 Sep;5(6):544-7.

12. Boyd J, Takahashi H, Waggoner SE, Jones LA, Hajek RA, Wharton JT, et al. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbesterol exposure in utero. Cancer 1996 Feb;77(3):507-13.

13. Hanselaar A, Von Loosbroek M, Schuurbiers O, Helmerhorst T, Bulten J, Bemhelm J. Clear cell adenocarcinoma of the vagina and cervix. Cancer 1997 Jul;79(11):2229-36.

14. Senekjian EK, Frey K, Herbst AL. Pelvic exenteration in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol 1989 Sep; 34(3):413-6.

15. Okamoto Y, Hiroto S, Soejima T, Maeda Y, Takada H, Hishikawa Y, et al. Radiotherapy for adenocarcinoma of the uterine cervix. Nippon Igaku Hoshasen Gakkai Zasshi 1997 Dec;57(14):936-41.

16. Herbst AL, Norusis MJ, Rosenow PJ, Welch RR, Scully RE. An analysis of 346 cases of clear cell adenocarcinoma of the vagina and cervix with emphasis on recurrence and survival. Gynecol Oncol 1979 Apr;7(2):111-22.

17. Novak E, Woodruff JD, Novak ER. Probable mesonephric orign of certain female genital tumor. Am J Obstet Gynecol 1954 Nov;68: 1222-42.

18. Anderson B, Watring WG, Edinger DD Jr, Small EC, Netland AT, Safaii H. Development of DES-associated clear cell carcinoma: the importance of regular screening. Obstet Gynecol. 1979 Mar;53(3):293-9.